Highest Priority Critically Important Antibiotics (HP CIAs) Protocol

TMTV Protocol for use of HP-CIA (Highest Priority Critically Important Antibiotics) – October 2023

  1. Use of Highest Priority Critically Important Antibiotics (HP CIAs), as defined by the European Medicines Agency, must be restricted for use used as a last resort under veterinary direction, backed up by either sensitivity or diagnostic testing.
  2. Highest Priority Critically Important Antibiotics (HP CIAs) such as 3rd & 4th generation Cephalosporins & Fluoroquinalones should not make up 1st line treatment protocols.
  3. Highest Priority Critically Important Antibiotics (HP CIAs) should not be used in any way for preventative care protocols.
  4. TMTV will strive to reduce its use and reliance on these products.
  5. At present there are several products in the dispensary which fall into the Highest Priority Critically Important Antibiotics (HP CIAs) category. These include: Marbocare, Baytril, Aurizon & Marbocyl. These drugs are only to be used as a last resort, where there are resistance issues that have been identified as a result of Culture and Sensitivity testing.